TG Therapeutics | TGTX - Le Chiffre D'Affaires De Vente





Ventes Changement Date
AbbVie USD 16.99B 1.99B 2026-06
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 10.1B 1.48B 2026-06
Ardelyx USD 94.47M 30.74M 2026-03
Arrowhead Research USD 75.23M 1.49M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Biogen USD 2.74B 490M 2026-06
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Curis USD 1.14M 1.41M 2025-12
Gilead Sciences USD 7.8B 800M 2026-06
J&J USD 25.31B 1.21B 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Novartis USD 14.41B 1.3B 2026-06
Novavax USD 147.14M 76.69M 2025-12
PTC Therapeutics USD 361M 88M 2026-06
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
TG Therapeutics USD 240.34M 45.54M 2026-06
Verastem USD 18.67M 1.14M 2026-03
Vertex Pharmaceuticals USD 3.33B 340M 2026-06